MORAb-028
Product Specifications
Target
Others
Related Pathways
Others
Bioactivity
MORAb-028 is a humanized IgG1 monoclonal antibody inhibitor targeting GD2. It exhibits potent antitumor activity by killing GD2-expressing target cells through complement-dependent cytotoxicity (CDC) . In EL-4-luc xenograft mouse models, MORAb-028 significantly reduces tumor growth. This compound is applicable for melanoma cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
249952-APC 100 µL
PDRG1 (p53 and DNA Damage Regulated 1, C20orf126, PDRG) (APC)
Sign In for Pricing
View Details 
148842 100 µg
BTLA, Control Peptide (B- and T-lymphocyte Associated Protein, B- and T-lymphocyte Attenuator, BTLA1, CD272, CD272 Antigen, FLJ16065, MGC129743)
Sign In for Pricing
View Details 
MBS2163595-01 0.1 mL
APC_Cy7-Linked Monoclonal Antibody to Complement C4-B (C4B)
Sign In for Pricing
View Details MBS2163595-02 0.2 mL
APC_Cy7-Linked Monoclonal Antibody to Complement C4-B (C4B)
Sign In for Pricing
View Details MBS2163595-03 0.5 mL
APC_Cy7-Linked Monoclonal Antibody to Complement C4-B (C4B)
Sign In for Pricing
View Details